Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer: A Systematic Review and Qualitative Assessment of the Literature.

Raphael MJ, Robinson A, Booth CM, O'Donnell J, Palmer M, Eisenhauer E, Brundage M.

JAMA Oncol. 2019 Sep 26. doi: 10.1001/jamaoncol.2019.3338. [Epub ahead of print]

PMID:
31556921
2.

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis.

Naci H, Davis C, Savović J, Higgins JPT, Sterne JAC, Gyawali B, Romo-Sandoval X, Handley N, Booth CM.

BMJ. 2019 Sep 18;366:l5221. doi: 10.1136/bmj.l5221.

3.

Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer.

Karim S, Mackillop WJ, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Booth CM.

Cancer Med. 2019 Oct;8(14):6258-6271. doi: 10.1002/cam4.2449. Epub 2019 Aug 31.

4.

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer.

Karim S, Booth CM, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Mackillop WJ.

Cancer Med. 2019 Sep;8(12):5590-5599. doi: 10.1002/cam4.2456. Epub 2019 Aug 12.

5.

Reliability of Oncology Value Framework Outputs: Concordance Between Independent Research Groups.

Del Paggio JC, Cheng S, Booth CM, Cheung MC, Chan KKW.

JNCI Cancer Spectr. 2018 Dec 13;2(3):pky050. doi: 10.1093/jncics/pky050. eCollection 2018 Jul.

6.

Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.

Saleh RR, Majeed H, Tibau A, Booth CM, Amir E.

Cancer. 2019 Jul 29. doi: 10.1002/cncr.32408. [Epub ahead of print]

PMID:
31355923
7.

Medical Oncology Workload in Europe: One Continent, Several Worlds.

Seruga B, Sullivan R, Fundytus A, Hopman WM, Ocana A, Joffe J, Bodoky G, Le Tourneau C, Vanderpuye V, Lopes G, Hammad N, Sengar M, Brundage MD, Booth CM.

Clin Oncol (R Coll Radiol). 2019 Jul 16. pii: S0936-6555(19)30278-X. doi: 10.1016/j.clon.2019.06.017. [Epub ahead of print]

PMID:
31324474
8.

Sociodemographic Factors and Stage of Cancer at Diagnosis: A Population-Based Study in South India.

Mathew A, George PS, Ramadas K, Mathew BS, Kumar A, Roshni S, Jayakumar KNL, Booth CM.

J Glob Oncol. 2019 Jul;5:1-10. doi: 10.1200/JGO.18.00160.

9.

Management of Cancer-Associated Intestinal Obstruction in the Final Year of Life.

Merchant SJ, Brogly SB, Booth CM, Goldie C, Peng Y, Nanji S, Patel SV, Lajkosz K, Baxter NN.

J Palliat Care. 2019 Jul 16:825859719861935. doi: 10.1177/0825859719861935. [Epub ahead of print]

PMID:
31307272
10.

Immunotherapy for Urothelial Cancer: Where Are the Randomized Trials?

Vera-Badillo FE, Tannock IF, Booth CM.

J Clin Oncol. 2019 Oct 10;37(29):2587-2591. doi: 10.1200/JCO.18.02257. Epub 2019 Jul 1. No abstract available.

PMID:
31260641
11.

Breast Cancer Care in South India: Is Practice Concordant With National Guidelines?

Vijaykumar DK, Arun S, Abraham AG, Hopman W, Robinson AG, Booth CM.

J Glob Oncol. 2019 Jul;5:1-7. doi: 10.1200/JGO.19.00052.

12.

Association Between Institutional Factors and Long-Term Survival Following Transjugular Intrahepatic Portosystemic Shunt.

Mah JM, DeWit Y, Djerboua M, Menard A, Booth CM, Flemming JA.

Hepatol Commun. 2019 Mar 25;3(6):838-846. doi: 10.1002/hep4.1345. eCollection 2019 Jun.

13.

India's new health scheme: what does it mean for cancer care?

Caduff C, Booth CM, Pramesh CS, Sullivan R.

Lancet Oncol. 2019 Jun;20(6):757-758. doi: 10.1016/S1470-2045(19)30322-5. No abstract available.

PMID:
31162087
14.

Cancer care workforce in Africa: perspectives from a global survey.

Vanderpuye V, Hammad N, Martei Y, Hopman WM, Fundytus A, Sullivan R, Seruga B, Lopes G, Sengar M, Brundage MD, Booth CM.

Infect Agent Cancer. 2019 May 21;14:11. doi: 10.1186/s13027-019-0227-8. eCollection 2019.

15.

PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis.

Ghate K, Amir E, Kuksis M, Hernandez-Barajas D, Rodriguez-Romo L, Booth CM, Vera-Badillo FE.

Cancer Treat Rev. 2019 Jun;76:51-56. doi: 10.1016/j.ctrv.2019.05.002. Epub 2019 May 16.

PMID:
31125908
16.

Would Regionalization of Systemic Cancer Therapy Improve the Quality of Cancer Care?

Raphael MJ, Siemens DR, Booth CM.

J Oncol Pract. 2019 Jul;15(7):349-356. doi: 10.1200/JOP.18.00671. Epub 2019 May 21. No abstract available.

PMID:
31112481
17.

Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment.

Gyawali B, Hwang TJ, Vokinger KN, Booth CM, Amir E, Tibau A.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:374-387. doi: 10.1200/EDBK_242229. Epub 2019 May 17.

PMID:
31099613
18.

Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma.

Warren M, Kolinsky M, Canil CM, Czaykowski P, Sridhar SS, Black PC, Booth CM, Kassouf W, Eapen L, Mukherjee SD, Blais N, Eigl BJ, Winquist E, Basappa NS, North SA; GUMOC.

Can Urol Assoc J. 2019 Apr 26:318-327. doi: 10.5489/cuaj.6015. [Epub ahead of print] No abstract available.

PMID:
31059420
19.

Neurotoxicity Among Survivors of Testicular Cancer: A Population-based Study.

Raphael MJ, Wei X, Karim S, Robinson AG, Bedard PL, Booth CM.

Clin Oncol (R Coll Radiol). 2019 Sep;31(9):653-658. doi: 10.1016/j.clon.2019.04.008. Epub 2019 May 2.

PMID:
31056287
20.

From the $80 hamburger to managing conflicts of interest with the pharmaceutical industry.

Booth CM, Detsky AS.

BMJ. 2019 May 3;365:l1939. doi: 10.1136/bmj.l1939. No abstract available.

PMID:
31053609
21.

Do not use robotic surgery in oncology patients when conventional surgical approaches are equally effective - Authors' reply.

Pramesh CS, Sullivan R, Booth CM.

Lancet Oncol. 2019 May;20(5):e241. doi: 10.1016/S1470-2045(19)30247-5. No abstract available.

PMID:
31044716
22.

What really matters at the end: perspectives from a patient, a family member and an oncologist.

Koven R, Nelson P, Booth CM.

CMAJ. 2018 Apr 16;190(15):E473-E475. doi: 10.1503/cmaj.171285. No abstract available.

23.

Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer.

Merchant SJ, Brogly SB, Booth CM, Goldie C, Nanji S, Patel SV, Lajkosz K, Baxter NN.

Ann Surg Oncol. 2019 Aug;26(8):2336-2345. doi: 10.1245/s10434-019-07320-z. Epub 2019 Apr 9.

PMID:
30969388
24.

Effectiveness in the Absence of Efficacy: Cautionary Tales From Real-World Evidence.

Karim S, Booth CM.

J Clin Oncol. 2019 May 1;37(13):1047-1050. doi: 10.1200/JCO.18.02105. Epub 2019 Mar 21. No abstract available.

PMID:
30897036
25.

Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care.

Pramesh CS, Chaturvedi H, Reddy VA, Saikia T, Ghoshal S, Pandit M, Babu KG, Ganpathy KV, Savant D, Mitera G, Sullivan R, Booth CM; National Cancer Grid.

Lancet Oncol. 2019 Apr;20(4):e218-e223. doi: 10.1016/S1470-2045(19)30092-0. Epub 2019 Mar 8. Review.

PMID:
30857957
26.

Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Underused across the 49th parallel.

Raphael MJ, Booth CM.

Can Urol Assoc J. 2019 Feb;13(2):29-31. doi: 10.5489/cuaj.5827. No abstract available.

27.

Imaging use for low back pain by Ontario primary care clinicians: protocol for a mixed methods study - the Back ON study.

French SD, Green ME, Bhatia RS, Peng Y, Hayden JA, Hartvigsen J, Ivers NM, Grimshaw JM, Booth CM, Rühland L, Norman KE.

BMC Musculoskelet Disord. 2019 Feb 2;20(1):50. doi: 10.1186/s12891-019-2427-1.

28.

Real-world data: towards achieving the achievable in cancer care.

Booth CM, Karim S, Mackillop WJ.

Nat Rev Clin Oncol. 2019 May;16(5):312-325. doi: 10.1038/s41571-019-0167-7. Review.

PMID:
30700859
29.

A systematic review of outcomes after salvage abdominoperineal resection for persistent or recurrent anal squamous cell cancer.

Ko G, Sarkaria A, Merchant SJ, Booth CM, Patel SV.

Colorectal Dis. 2019 Jun;21(6):632-650. doi: 10.1111/codi.14569. Epub 2019 Mar 22.

PMID:
30689272
30.

Medical oncology job satisfaction: Results of a global survey.

Raphael MJ, Fundytus A, Hopman WM, Vanderpuye V, Seruga B, Lopes G, Hammad N, Sengar M, Brundage MD, Sullivan R, Booth CM.

Semin Oncol. 2019 Feb;46(1):73-82. doi: 10.1053/j.seminoncol.2018.12.006. Epub 2019 Jan 2.

PMID:
30685074
31.

Do doctors who order more routine medical tests diagnose more cancers? A population-based study from Ontario Canada.

Hall SF, Webber C, Groome PA, Booth CM, Nguyen P, DeWit Y.

Cancer Med. 2019 Feb;8(2):850-859. doi: 10.1002/cam4.1925. Epub 2019 Jan 4.

32.

Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study.

Flemming JA, Dewit Y, Mah JM, Saperia J, Groome PA, Booth CM.

Lancet Gastroenterol Hepatol. 2019 Mar;4(3):217-226. doi: 10.1016/S2468-1253(18)30339-X. Epub 2018 Dec 17.

PMID:
30573390
33.

Delivery of chemotherapy for testicular cancer in routine practice: A population-based study.

Karim S, Wei X, Leveridge MJ, Siemens DR, Robinson AG, Bedard PL, Booth CM.

Urol Oncol. 2019 Mar;37(3):183.e17-183.e24. doi: 10.1016/j.urolonc.2018.10.025. Epub 2018 Nov 23.

PMID:
30478011
34.

Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.

Kitchlu A, McArthur E, Amir E, Booth CM, Sutradhar R, Majeed H, Nash DM, Silver SA, Garg AX, Chan CT, Kim SJ, Wald R.

J Natl Cancer Inst. 2018 Nov 13. doi: 10.1093/jnci/djy167. [Epub ahead of print]

PMID:
30423160
35.

Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study.

Brennan K, Karim S, Doiron RC, Siemens DR, Booth CM.

Bladder Cancer. 2018 Oct 29;4(4):419-428. doi: 10.3233/BLC-180184.

36.

Use of radiotherapy for bladder cancer: A population-based study of evolving referral and practice patterns.

Wei X, Siemens DR, Mackillop WJ, Booth CM.

Can Urol Assoc J. 2019 Apr;13(4):92-101. doi: 10.5489/cuaj.5447. Epub 2018 Sep 27.

37.

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials.

Tibau A, Molto C, Borrell M, Del Paggio JC, Barnadas A, Booth CM, Amir E.

JAMA Oncol. 2018 Nov 1;4(11):1610-1611. doi: 10.1001/jamaoncol.2018.4300. No abstract available.

38.

Why patients receive treatments that are minimally effective?

Booth CM, Detsky AS.

Nat Rev Clin Oncol. 2019 Jan;16(1):3-4. doi: 10.1038/s41571-018-0101-4. No abstract available.

PMID:
30250215
39.

Palliative Care Program Development in a Low- to Middle-Income Country: Delivery of Care by a Nongovernmental Organization in India.

Krishnan A, Rajagopal MR, Karim S, Sullivan R, Booth CM.

J Glob Oncol. 2018 Sep;4:1-8. doi: 10.1200/JGO.17.00168.

40.

A Population-based Study of Survival Impact of New Targeted and Immune-based Therapies for Metastatic or Unresectable Melanoma.

Hanna TP, Nguyen P, Baetz T, Booth CM, Eisenhauer E.

Clin Oncol (R Coll Radiol). 2018 Oct;30(10):609-617. doi: 10.1016/j.clon.2018.05.005. Epub 2018 Jun 28.

41.

Documenting Goals of Care Among Patients With Advanced Cancer: Results of a Quality Improvement Initiative.

Karim S, Harle I, O'Donnell J, Li S, Booth CM.

J Oncol Pract. 2018 Sep;14(9):e557-e565. doi: 10.1200/JOP.18.00031. Epub 2018 Aug 16.

PMID:
30113873
42.

Delivery of Pediatric Cancer Care in Mexico: A National Survey.

Rodriguez-Romo L, Olaya Vargas A, Gupta S, Shalkow-Klincovstein J, Vega-Vega L, Reyes-Lopez A, Cicero-Oneto C, Mejia-Arangure J, Gonzalez-Ramella O, Pineiro-Retif R, Lopez-Facundo A, de Los Angeles Del Campo-Martinez M, Tejocote I, Brennan K, Booth CM.

J Glob Oncol. 2018 Jul;4:1-12. doi: 10.1200/JGO.17.00238.

43.

Disease Characteristics, Clinical Management, and Outcomes of Young Patients With Colon Cancer: A Population-based Study.

Rodriguez L, Brennan K, Karim S, Nanji S, Patel SV, Booth CM.

Clin Colorectal Cancer. 2018 Dec;17(4):e651-e661. doi: 10.1016/j.clcc.2018.06.007. Epub 2018 Jul 3.

PMID:
30061036
44.

Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care.

Fundytus A, Hopman WM, Hammad N, Biagi JJ, Sullivan R, Vanderpuye V, Seruga B, Lopes G, Sengar M, Brundage MD, Booth CM.

Curr Oncol. 2018 Jun;25(3):206-212. doi: 10.3747/co.25.3999. Epub 2018 Jun 28.

45.

Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis.

Gregg RW, Vera-Badillo FE, Booth CM, Mahmud A, Brundage M, Leveridge MJ, Hanna TP.

Crit Rev Oncol Hematol. 2018 Aug;128:58-64. doi: 10.1016/j.critrevonc.2018.05.005. Epub 2018 May 22. Review.

PMID:
29958631
46.

The role of sex in the outcomes of patients with biliary tract cancers remains unclear: A population-based study.

Lemke M, DeWit Y, Nanji S, Booth CM, Flemming JA.

Am J Surg. 2018 Dec;216(6):1118-1121. doi: 10.1016/j.amjsurg.2018.05.021. Epub 2018 Jun 19.

PMID:
29934122
47.

Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis.

Gandhi N, Krishna S, Booth CM, Breau RH, Flood TA, Morgan SC, Schieda N, Salameh JP, McGrath TA, McInnes MDF.

BJU Int. 2018 Nov;122(5):744-753. doi: 10.1111/bju.14366. Epub 2018 Jun 3.

PMID:
29727910
48.

Factors associated with imaging in patients with early breast cancer after initial treatment.

Enright K, Desai T, Sutradhar R, Gonzalez A, Powis M, Taback N, Booth CM, Trudeau ME, Krzyzanowska MK.

Curr Oncol. 2018 Apr;25(2):126-132. doi: 10.3747/co.25.3838. Epub 2018 Apr 30.

49.

Risk-based reboot for global lab biosafety.

Kojima K, Booth CM, Summermatter K, Bennett A, Heisz M, Blacksell SD, McKinney M.

Science. 2018 Apr 20;360(6386):260-262. doi: 10.1126/science.aar2231. Epub 2018 Apr 19. No abstract available.

PMID:
29674576
50.

Temporal trends in management and outcomes of testicular cancer: A population-based study.

Leveridge MJ, Siemens DR, Brennan K, Izard JP, Karim S, An H, Mackillop WJ, Booth CM.

Cancer. 2018 Jul 1;124(13):2724-2732. doi: 10.1002/cncr.31390. Epub 2018 Apr 16.

Supplemental Content

Loading ...
Support Center